Qy. Yue et J. Sawe, DIFFERENT EFFECTS OF INHIBITORS ON THE O-DEMETHYLATION AND N-DEMETHYLATION OF CODEINE IN HUMAN LIVER-MICROSOMES, European Journal of Clinical Pharmacology, 52(1), 1997, pp. 41-47
Objective: The O- and N-demethylation of codeine is catalysed by CYP2D
6 and CYP3A4 respectively. The formation rates of morphine by O-demeth
ylation and norcodeine by N-demethylation were studied in two sets of
human liver microsomes. Results: Relatively high K-m values were found
for both O- and N-demethylations, suggesting a low affinity to the co
rresponding enzymes. The inhibitory effects of various drugs were foun
d to be different for O- and N-demethylations. The substrates of CYP2D
6 such as thioridazine, amitriptyline and metoprolol inhibited the O-d
emethylation of codeine preferentially, while the substrates of CYP3A4
such as cyclosporine A, midazolam and erythromycin were all strong in
hibitors of the N-demethylation of codeine. Quinidine and lignocaine,
although they are substrates of CYP3A, showed preferential inhibition
over the O-demethylation of codeine, suggesting a low affinity to the
CYP3A. Methadone and dextropropoxyphene showed a preferential inhibiti
on of CYP2D6 over CYP3A, while theophylline did not inhibit the O- or
N-demethylation to a greater extent. Conclusion: It seems that there w
as a good correspondence between the capacity of drugs to inhibit the
O- and N-demethylation of codeine in human liver microsomes and their
apparent metabolism by CYP2D6 or CYP3A4, respectively in vivo in man,
suggesting that this in vitro inhibition test may be a useful screen f
or drugs which interact with these two important drug-metabolising enz
ymes.